ConductScience.org, home

Trial · NCT01191944

Results by group50

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Change From Baseline in Unified Parkinsons Disease Rating Scale (UPDRS) Parts II+III Score at Week 18Pramipexole ER-13.807Standard Error 0.6547Units on a scale
Change From Baseline in Unified Parkinsons Disease Rating Scale (UPDRS) Parts II+III Score at Week 18Pramipexole IR-13.047Standard Error 0.6434Units on a scale
Change From Baseline in Percentage Off-time During Waking Hours at Week 18Pramipexole ER-6.962Standard Error 1.5072Percentage off-time
Change From Baseline in Percentage Off-time During Waking Hours at Week 18Pramipexole IR-7.443Standard Error 1.5362Percentage off-time
Change From Baseline in Duration of Off-time During Waking Hours at Week 18Pramipexole ER-1.044Standard Error 0.2256hours
Change From Baseline in Duration of Off-time During Waking Hours at Week 18Pramipexole IR-1.098Standard Error 0.2300hours
Responder in Percentage Off-time During Waking Hours at Week 18Pramipexole ERResponder58Participants
Responder in Percentage Off-time During Waking Hours at Week 18Pramipexole IRResponder59Participants
Responder in Percentage Off-time During Waking Hours at Week 18Pramipexole ERNon-Responder52Participants
Responder in Percentage Off-time During Waking Hours at Week 18Pramipexole IRNon-Responder47Participants
Change From Baseline in Percentage On-time Without Dyskinesia at Week 18Pramipexole ER7.028Standard Error 1.9274Percentage of on-time
Change From Baseline in Percentage On-time Without Dyskinesia at Week 18Pramipexole IR4.265Standard Error 1.9643Percentage of on-time
Change From Baseline in Percentage On-time With Non-troublesome Dyskinesia at Week 18Pramipexole ER-0.235Standard Error 1.0807Percentage of on-time
Change From Baseline in Percentage On-time With Non-troublesome Dyskinesia at Week 18Pramipexole IR3.275Standard Error 1.1013Percentage of on-time
Change From Baseline in Percentage On-time Without or With Non-troublesome Dyskinesia at Week 18Pramipexole ER6.855Standard Error 1.5672Percentage of on-time
Change From Baseline in Percentage On-time Without or With Non-troublesome Dyskinesia at Week 18Pramipexole IR7.476Standard Error 1.5973Percentage of on-time
Change From Baseline in Percentage On-time With Troublesome Dyskinesia at Week 18Pramipexole ER-0.142Standard Error 0.3398Percentage of on-time
Change From Baseline in Percentage On-time With Troublesome Dyskinesia at Week 18Pramipexole IR0.226Standard Error 0.3463Percentage of on-time
Change From Baseline in Duration of On-time Without Dyskinesia at Week 18Pramipexole ER1.026Standard Error 0.3076hours
Change From Baseline in Duration of On-time Without Dyskinesia at Week 18Pramipexole IR0.496Standard Error 0.3134hours

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01191944/results